The Soglio Innovation Catalyst is open to very early life science ventures that meet the following criteria:
Life sciences focus: including diagnostics, medical devices, and digital health, but excluding therapeutics (drug development) in 2026.
Pre‑equity stage: applicants should not yet have raised their first equity/VC round; however, a plan or intention to raise a first equity round in 2027/2028 should exist.
Not required to be incorporated: teams or individuals may apply even if the company is not yet founded, as long as a motivated team or individual and a clear concept exist.
Some early proof‑of‑concept data supporting the idea.